Marker Therapeutics is trading at $1.05, up 14.13%, amid a biotech sector rally.
- The XBI was up 2.20% in regular trading, supporting a sector explanation rather than a company-specific catalyst.
- Marker Therapeutics’ investor-relations page lists its latest press release as September 22, with no October 16 announcement shown.
- A Zacks stock-screening feature mentions the company but does not link it to the price move.